当前位置:首页 - 行情中心 - 南微医学(688029) - 财务分析 - 资产负债表

南微医学

(688029)

  

流通市值:136.49亿  总市值:136.49亿
流通股本:1.88亿   总股本:1.88亿

资产负债表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
流动资产:
货币资金911,587,949.171,209,267,660.84660,730,878.76864,082,187.32
应收票据及应收账款401,368,812.22410,740,243.09346,290,326.81333,580,498.71
其中:应收票据-737,782.46295,115.7-
应收账款401,368,812.22410,002,460.63345,995,211.11333,580,498.71
预付款项32,921,144.9828,399,198.0828,578,302.4828,557,802.42
其他应收款合计13,405,422.7711,715,645.5311,821,389.947,227,075.29
存货517,474,251.87521,509,657.18566,900,481.18560,929,781.98
其他流动资产967,229,238.991,109,174,925.4898,709,396.91850,993,255.04
流动资产平衡项目0000
流动资产合计3,208,432,794.63,290,807,580.173,147,058,408.543,104,045,850.04
非流动资产:
长期股权投资48,718,464.7349,705,900.6548,477,593.8545,934,020.52
其他权益工具投资7,741,026.017,790,185.188,940,499.978,940,499.97
其他非流动金融资产14,885,030.715,015,631.01--
固定资产294,673,857.34294,702,931.14289,338,423.14285,005,938.08
在建工程402,535,853.88363,799,657.31358,162,899.37347,121,688.39
使用权资产37,124,996.636,076,455.5819,767,616.4421,665,599.11
无形资产83,706,929.2289,084,072.1691,645,013.6288,542,614.47
商誉180,179,934.34177,881,930.08165,964,751.04131,568,006.99
长期待摊费用29,969,050.9330,326,635.7430,610,771.1631,184,909.48
递延所得税资产29,729,455.0728,718,906.5722,774,663.1621,147,810.44
其他非流动资产39,730,626.258,763,124.636,978,751.3213,139,909.38
非流动资产平衡项目0000
非流动资产合计1,168,995,225.071,101,865,430.051,042,660,983.07994,250,996.83
资产平衡项目0000
资产总计4,377,428,019.674,392,673,010.224,189,719,391.614,098,296,846.87
流动负债:
短期借款--35,000,000-
应付票据及应付账款258,803,212.78273,792,956.67278,283,743.88317,210,757.34
其中:应付票据1,775,561.628,385,045.2110,531,430.21-
应付账款257,027,651.16265,407,911.46267,752,313.67317,210,757.34
预收款项1,425,461.311,116,560.781,685,000.61,663,394.93
合同负债48,554,646.0670,896,927.2239,913,741.9365,775,126.29
应付职工薪酬70,123,574.88158,911,653.6187,333,213.4574,087,860.2
应交税费47,864,775.846,311,648.9241,390,407.0345,960,960.29
其他应付款合计76,915,322.3278,561,410.4262,183,052.6559,666,217.41
一年内到期的非流动负债9,060,061.8310,858,097.125,356,041.787,599,503.26
其他流动负债5,325,289.39,070,710.96633,453.627,658,579.97
流动负债平衡项目0000
流动负债合计518,072,344.28649,519,965.7551,778,654.94579,622,399.69
非流动负债:
租赁负债27,210,332.0525,063,609.0213,706,756.3911,430,997.14
长期应付款37,204,410.9839,204,410.9845,254,410.9844,754,410.98
递延收益9,706,193.057,273,857.37,636,922.78,124,638.42
递延所得税负债1,680,968.961,452,727.021,913,984.531,968,864.5
非流动负债平衡项目0000
非流动负债合计75,801,905.0472,994,604.3268,512,074.666,278,911.04
负债平衡项目0000
负债合计593,874,249.32722,514,570.02620,290,729.54645,901,310.73
所有者权益(或股东权益):
实收资本(或股本)187,847,422187,847,422187,847,422187,847,422
资本公积1,916,350,696.711,916,350,696.711,916,350,696.711,916,350,696.71
减:库存股30,000,000---
其他综合收益2,184,463.236,243,621.675,084,534.612,114,331.82
盈余公积109,690,385.48109,690,385.48109,690,385.48109,690,385.48
未分配利润1,535,252,260.821,391,787,818.741,292,445,269.981,170,217,312.75
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计3,721,325,228.243,611,919,944.63,511,418,308.773,396,220,148.76
少数股东权益62,228,542.1158,238,495.658,010,353.356,175,387.38
股东权益平衡项目0000
股东权益合计3,783,553,770.353,670,158,440.23,569,428,662.073,452,395,536.14
负债和股东权益合计4,377,428,019.674,392,673,010.224,189,719,391.614,098,296,846.87
公告日期2024-04-262024-04-262023-10-282023-08-08
审计意见(境内)标准无保留意见
TOP↑